NeoTract, Inc., today announced that the Centers for Medicare and Medicaid Services (CMS) have issued two new codes that describe the UroLift® implant procedure for the treatment of enlarged prostate ...

UroLift is a minimally invasive treatment option for benign prostatic hyperplasia (BPH), also called enlarged prostate. Medicare covers the UroLift procedure when a doctor deems it medically necessary ...

PLEASANTON, Calif.--(BUSINESS WIRE)--NeoTract, Inc., welcomed the September announcement by NICE that its UroLift® System (Prostatic Urethral Lift) to treat an enlarged prostate (benign prostatic ...

PORTSMOUTH, Va. (WAVY) – An enlarged prostate is a fairly common condition among men as they get older. If you or a loved one is dealing with this condition, you’ll want to hear about the UroLift ...

An enlarged prostate is a common problem for older men and the frequent urination the condition can cause has a big impact on quality of life, but a new procedure called Urolift is offering relief. "I ...

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...

PLEASANTON, Calif., April 6, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...

More than 50% of men over the age of 50 suffer from benign prostatic hyperplasia, also known as an enlarged prostate. While BPH is common for older men, causing the frequent urge to urinate — ...

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.

National Institute for Health and Care Excellence (NICE) could give major boost to UroLift ® System adoption on the NHS across the UK with guidance finding the treatment is less costly than other ...